16:31:45United States

Immuron Limited (IMRN)

NASDAQ

Key stats Fiscal year 2025

Income statement

Revenue
7,287,002 48.6%
Net income
-5,215,987
Gross profit
4,765,099
Operating income
-5,344,548
Earnings per share
-2.26
R&D expense
3,597,296

Growth and profitability

Gross margin
65.39
Operating margin
-73.34
Net margin
-71.58
Return on equity
-64.64
Return on assets
-51.49

Balance sheet

Total assets
10,129,842
Total liabilities
2,060,787
Shareholders' equity
8,069,055
Cash and equivalents
2,830,526
Current ratio
5.09

Cash flow and ratios

Operating cash flow
-6,136,949

Shareholder returns

Shares outstanding
322,848,081
Book value per share
0.02
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Carlton, Victoria, C3
Exchange
NASDAQ
Fiscal year end
06-30
Industry (SEC)
Pharmaceutical Preparations

Fiscal year end: · Source: SEC EDGAR

Immuron Limited trades on NASDAQ under the ticker symbol IMRN. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis